Drug Type Small molecule drug |
Synonyms SH-3765, SH3765 |
Target |
Mechanism PRMT5 inhibitors(Protein arginine methyltransferase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | CN | 24 Aug 2021 | |
Neoplasms | Phase 1 | CN | 24 Aug 2021 | |
Non-Hodgkin Lymphoma | Phase 1 | CN | 24 Aug 2021 | |
Solid tumor | Phase 1 | CN | 24 Aug 2021 |